Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases

Mauro Signorelli, Luca Guerra, Alessandro Buda, Maria Picchio, Giorgia Mangili, Tiziana Dell'Anna, Sandro Sironi, Cristina Messa

Research output: Contribution to journalArticle

Abstract

Background: High risk clinical stage I endometrial cancer (grade 2 and deep myometrial invasion, grade 3 and serous and clear-cell carcinoma) had 10-35% of nodal involvement. Surgical staging is considered reasonable in this setting of women, although unnecessary in 70-90%. The purpose of this study was to determine prospectively the diagnostic accuracy of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 18F-FDG PET/CT in the detection of nodal metastases in patients with high risk endometrial cancer. Methods: Eleven women with grade 2 and deep myometrial invasion and 26 with grade 3 endometrial cancer underwent 18F-FDG PET/CT, followed by total hysterectomy, bilateral salpingo-oophorectomy and systematic pelvic lymphadenectomy. Histopathological findings served as the reference standard. Diagnostic performance of 18F-FDG PET/CT in nodal disease detection was reported in terms of accuracy value both in a patient-based and a lesion site-based analysis. Results: Pelvic nodes metastases were found at histopathological analysis in 9 of the 37 patients (24.3%). Patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT for detection of nodal disease were 77.8%, 100.0%, 100.0%, 93.1% and 94.4%, respectively. Nodal lesion site-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT were 66.7%, 99.4%, 90.9%, 97.2% and 96.8%, respectively. Conclusion: This study shows that 18F-FDG PET/CT is an accurate method for the presurgical evaluation of pelvic nodes metastases. The high negative predictive value may be useful in selecting patients who only may benefit from lymphadenectomy, minimizing operative and surgical complications.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalGynecologic Oncology
Volume115
Issue number2
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Fluorodeoxyglucose F18
Endometrial Neoplasms
Neoplasm Metastasis
Lymph Node Excision
Sensitivity and Specificity
Ovariectomy
Hysterectomy
Carcinoma

Keywords

  • 18F-FDG PET/CT imaging
  • Endometrial cancer
  • High risk
  • Lymphadenectomy
  • Nodal metastases

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer : Detection of pelvic nodal metastases. / Signorelli, Mauro; Guerra, Luca; Buda, Alessandro; Picchio, Maria; Mangili, Giorgia; Dell'Anna, Tiziana; Sironi, Sandro; Messa, Cristina.

In: Gynecologic Oncology, Vol. 115, No. 2, 11.2009, p. 231-235.

Research output: Contribution to journalArticle

@article{52cc150986264a44b94ef3962276807c,
title = "Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases",
abstract = "Background: High risk clinical stage I endometrial cancer (grade 2 and deep myometrial invasion, grade 3 and serous and clear-cell carcinoma) had 10-35{\%} of nodal involvement. Surgical staging is considered reasonable in this setting of women, although unnecessary in 70-90{\%}. The purpose of this study was to determine prospectively the diagnostic accuracy of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 18F-FDG PET/CT in the detection of nodal metastases in patients with high risk endometrial cancer. Methods: Eleven women with grade 2 and deep myometrial invasion and 26 with grade 3 endometrial cancer underwent 18F-FDG PET/CT, followed by total hysterectomy, bilateral salpingo-oophorectomy and systematic pelvic lymphadenectomy. Histopathological findings served as the reference standard. Diagnostic performance of 18F-FDG PET/CT in nodal disease detection was reported in terms of accuracy value both in a patient-based and a lesion site-based analysis. Results: Pelvic nodes metastases were found at histopathological analysis in 9 of the 37 patients (24.3{\%}). Patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT for detection of nodal disease were 77.8{\%}, 100.0{\%}, 100.0{\%}, 93.1{\%} and 94.4{\%}, respectively. Nodal lesion site-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT were 66.7{\%}, 99.4{\%}, 90.9{\%}, 97.2{\%} and 96.8{\%}, respectively. Conclusion: This study shows that 18F-FDG PET/CT is an accurate method for the presurgical evaluation of pelvic nodes metastases. The high negative predictive value may be useful in selecting patients who only may benefit from lymphadenectomy, minimizing operative and surgical complications.",
keywords = "18F-FDG PET/CT imaging, Endometrial cancer, High risk, Lymphadenectomy, Nodal metastases",
author = "Mauro Signorelli and Luca Guerra and Alessandro Buda and Maria Picchio and Giorgia Mangili and Tiziana Dell'Anna and Sandro Sironi and Cristina Messa",
year = "2009",
month = "11",
doi = "10.1016/j.ygyno.2009.07.020",
language = "English",
volume = "115",
pages = "231--235",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer

T2 - Detection of pelvic nodal metastases

AU - Signorelli, Mauro

AU - Guerra, Luca

AU - Buda, Alessandro

AU - Picchio, Maria

AU - Mangili, Giorgia

AU - Dell'Anna, Tiziana

AU - Sironi, Sandro

AU - Messa, Cristina

PY - 2009/11

Y1 - 2009/11

N2 - Background: High risk clinical stage I endometrial cancer (grade 2 and deep myometrial invasion, grade 3 and serous and clear-cell carcinoma) had 10-35% of nodal involvement. Surgical staging is considered reasonable in this setting of women, although unnecessary in 70-90%. The purpose of this study was to determine prospectively the diagnostic accuracy of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 18F-FDG PET/CT in the detection of nodal metastases in patients with high risk endometrial cancer. Methods: Eleven women with grade 2 and deep myometrial invasion and 26 with grade 3 endometrial cancer underwent 18F-FDG PET/CT, followed by total hysterectomy, bilateral salpingo-oophorectomy and systematic pelvic lymphadenectomy. Histopathological findings served as the reference standard. Diagnostic performance of 18F-FDG PET/CT in nodal disease detection was reported in terms of accuracy value both in a patient-based and a lesion site-based analysis. Results: Pelvic nodes metastases were found at histopathological analysis in 9 of the 37 patients (24.3%). Patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT for detection of nodal disease were 77.8%, 100.0%, 100.0%, 93.1% and 94.4%, respectively. Nodal lesion site-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT were 66.7%, 99.4%, 90.9%, 97.2% and 96.8%, respectively. Conclusion: This study shows that 18F-FDG PET/CT is an accurate method for the presurgical evaluation of pelvic nodes metastases. The high negative predictive value may be useful in selecting patients who only may benefit from lymphadenectomy, minimizing operative and surgical complications.

AB - Background: High risk clinical stage I endometrial cancer (grade 2 and deep myometrial invasion, grade 3 and serous and clear-cell carcinoma) had 10-35% of nodal involvement. Surgical staging is considered reasonable in this setting of women, although unnecessary in 70-90%. The purpose of this study was to determine prospectively the diagnostic accuracy of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 18F-FDG PET/CT in the detection of nodal metastases in patients with high risk endometrial cancer. Methods: Eleven women with grade 2 and deep myometrial invasion and 26 with grade 3 endometrial cancer underwent 18F-FDG PET/CT, followed by total hysterectomy, bilateral salpingo-oophorectomy and systematic pelvic lymphadenectomy. Histopathological findings served as the reference standard. Diagnostic performance of 18F-FDG PET/CT in nodal disease detection was reported in terms of accuracy value both in a patient-based and a lesion site-based analysis. Results: Pelvic nodes metastases were found at histopathological analysis in 9 of the 37 patients (24.3%). Patient-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT for detection of nodal disease were 77.8%, 100.0%, 100.0%, 93.1% and 94.4%, respectively. Nodal lesion site-based sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-FDG PET/CT were 66.7%, 99.4%, 90.9%, 97.2% and 96.8%, respectively. Conclusion: This study shows that 18F-FDG PET/CT is an accurate method for the presurgical evaluation of pelvic nodes metastases. The high negative predictive value may be useful in selecting patients who only may benefit from lymphadenectomy, minimizing operative and surgical complications.

KW - 18F-FDG PET/CT imaging

KW - Endometrial cancer

KW - High risk

KW - Lymphadenectomy

KW - Nodal metastases

UR - http://www.scopus.com/inward/record.url?scp=70349731442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349731442&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2009.07.020

DO - 10.1016/j.ygyno.2009.07.020

M3 - Article

C2 - 19695685

AN - SCOPUS:70349731442

VL - 115

SP - 231

EP - 235

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -